Arrivent Biopharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$31.74

+0.38 (+1.21%)

As of Jun 21, 10:14 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target -19.3% upside

Low Target $15.99

Average Target $25.60

High Target $32.44

Current Price $31.74

Current
$31.74

Target
$25.60

$15.99 $25.60 avg $32.44

Scenario Analysis

Bear Case

$15.99

-49.6%

Low target

Base Case

$25.60

-19.3%

Avg target

Bull Case

$32.44

+2.2%

High target

Risk/Reward

0.0x

Unfavorable

Price in Context

52-Week High

$33.62

-5.6% from high

52-Week Low

$16.10

+97.1% from low

Target vs 52W High

$25.60

-23.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%